In December 2018, the Medicines and Healthcare Products Regulatory Agency (MHRA) announced that all oral lidocaine-containing products for teething in children would be reclassified from General Sale medicines to Pharmacy medicines. a) What change must manufacturers make to the packaging of this product to comply with labelling legislation? (1 mark)   b) What change should occur in pharmacies regarding where these products are displayed? Is this change a legal requirement or a good practice requirement? (2 marks)   c) Describe how the legal sale of these products from a pharmacy is affected by this change in classification. Include in your answer a definition of any key terms.  (2 marks)

Which of the following prescription types does NOT require a signature of a prescriber?

Which is a pyramid-shaped gland with a cortex of endocrine cells and a medulla of neuroendocrine cells?

A 37-year-old woman presents to your pharmacy with classic symptoms of migraine and discloses that she has already tried to self-treat with paracetamol 500mg tablets. You are aware that sumatriptan is a potential treatment option that you could supply.   What are the requirements that MUST be met before sumatriptan can be sold to this patient? (5 marks)

 What is the recommended number of days’ supply that a prescriber should NOT exceed (as good practice) when prescribing MST Continus® (morphine MR) tablets 30mg?

How do we measure kidney function?

 Which of the following products kept in a pharmacy is NOT licensed as a medical device?

 A 74-year-old patient has just been diagnosed with atrial fibrillation and is unsure whether to take warfarin or a direct acting anticoagulant (DOAC).   Which of the following statements regarding anticoagulant therapy is INCORRECT?

What carries an oocyte to the uterus?

A 22-year-old man has been referred to a consultant gastroenterologist with a suspected diagnosis of Crohn’s disease.            Which of the following is NOT a symptom routinely associated with untreated Crohn’s disease?